Fidelity International’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-39,161
Closed -$1.5M 829
2023
Q3
$1.5M Sell
39,161
-207,002
-84% -$8.48M ﹤0.01% 658
2023
Q2
$8.88M Sell
246,163
-242,773
-50% -$8.28M 0.01% 506
2023
Q1
$18.7M Sell
488,936
-238,914
-33% -$11.2M 0.02% 393
2022
Q4
$41.4M Sell
727,850
-272,719
-27% -$14M 0.05% 322
2022
Q3
$39.6M Buy
+1,000,569
New +$44.2M 0.05% 320

Other funds holding HALO

Fidelity International's HALO Position: Q4 2023 in Review

Fidelity International sold out of Halozyme (HALO) in Q4 2023, closing a stake of 39,161 shares — an estimated $1.5M sold.

Fidelity International first reported a position in HALO in Q3 2022 and held it in 5 quarters. The position peaked at $41.4M in Q4 2022. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.

  • Fidelity International reported no remaining Halozyme position as of Q4 2023 after selling out during the quarter.
  • Fidelity International sold 39,161 Halozyme shares in Q4 2023, an estimated $1.5M.
  • Fidelity International first reported a position in Halozyme in Q3 2022 and held it in 5 quarters.
  • Fidelity International's Halozyme position peaked at $41.4M in Q4 2022.
  • 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.

Based on Fidelity International's 13F filing for Q4 2023, filed 13 Feb 2024.